Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating vascular eye disorders with ActRII antagonists

Methods for treating vascular eye disorders with ActRII antagonists

US Patent 11524990 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activin-ActRII antagonists and uses for treating anemia2022
Methods and compositions for treating ulcers2022
Methods for treating myelodysplastic syndromes and sideroblastic anemias2020
Methods for treating vascular eye disorders with actrii antagonists2020
Methods for treating vascular eye disorders with actrii antagonists2020
Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB 2019
Methods for treating myelodysplastic syndromes and sideroblastic anemias2019
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels2018
Follistatin fusion proteins and uses thereof2018
Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide2017
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreti2016
Antagonists of activin-actriia and uses for increasing red blood cell levels2014